Healthcare -
Biotechnology - NASDAQ - US
$ 0.7817
0.786 %
$ 42.6 M
Market Cap
9.77
P/E
SPRO - STOCK-BASED COMPENSATION
Stock-based Compensation SPRO - Spero Therapeutics, Inc.
7.93 M
LAST VALUE
-8.29%
2 YEAR CAGR
23.61%
5 YEAR CAGR
0.00%
10 YEAR CAGR